CDKN2A and precursor B-cell acute lymphoblastic leukemia: In a recent report, PAX5 deletion was observed in only 10 % and 18 % in children and adult B-ALL, respectively; notably PAX5 deletion was frequently accompanied by deletion of CDKN2A (83.3 % of children and 100.0 % of adults) [28].